Go Pro

Stock Analyst Downgrades

Explore the most recent stock downgrades, analyst downgrades, and changes to stock analyst ratings in this continuously updated list of analyst recommendations. This page captures each newly issued downgrade, including adjustments to stock ratings, price targets, and analyst coverage, making it easy to follow all the latest downgrades and rating changes.

CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetails
Swedish Orphan Biovitrum stock logo
BIOVF
Swedish Orphan Biovitrum
Downgraded by $48.00
Hold
Brightstar Lottery stock logo
BRSL
Brightstar Lottery
Downgraded by$10.92
-2.5%
BuyHold
Salesforce Inc. stock logo
CRM
Salesforce
Downgraded by $158.12
-0.2%
$253.00 ➝ $166.00BuyNeutral
Doximity, Inc. stock logo
DOCS
Doximity
Downgraded by $20.53
-1.7%
Underperform
Evommune, Inc. stock logo
EVMN
Evommune
Downgraded by$15.08
-40.1%
OutperformMarket Perform
Fortinet, Inc. stock logo
FTNT
Fortinet
Downgraded by $155.42
+2.7%
$102.00HoldReduce
Iridium Communications Inc stock logo
IRDM
Iridium Communications
Downgraded by $54.59
+25.4%
OutperformMarket Perform
The Progressive Corporation stock logo
PGR
Progressive
Downgraded by$219.13
-2.3%
$205.00Equal WeightUnderweight
Roblox Corporation stock logo
RBLX
Roblox
Downgraded by$54.37
+14.3%
BuyUnderperform
Sezzle Inc. stock logo
SEZL
Sezzle
Downgraded by$170.70
+0.1%
OutperformMarket Perform
Your book attached (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
Synaptics Incorporated stock logo
SYNA
Synaptics
Downgraded by$117.38
-3.0%
$125.00BuyHold
Theravance Biopharma, Inc. stock logo
TBPH
Theravance Biopharma
Downgraded by$17.06
-3.2%
BuyNeutral
Bio-Techne Corp stock logo
TECH
Bio-Techne
Downgraded by $70.90
-0.1%
BuyHold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 10:01 PM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports  and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.